Auckland District Health Board Home | Contact Us | Phone Directory | Search     
Auckland District Health Board  
part of menu  

Trauma Homepage
Up
Navigation Bar Image
external link iconMinistry of Health
external link iconNZ Government

    horizontal line
 ©Copyright
 Published: 28/09/2006


Stenting in Trauma

Grant Christey


Slide1.JPG
Slide1.JPG
20.83 KB
Slide2.JPG
Slide2.JPG
23.47 KB
Slide3.JPG
Slide3.JPG
50.91 KB
Slide4.JPG
Slide4.JPG
42.48 KB
Slide5.JPG
Slide5.JPG
53.72 KB
Slide6.JPG
Slide6.JPG
40.81 KB
Slide7.JPG
Slide7.JPG
43.08 KB
Slide8.JPG
Slide8.JPG
45.98 KB
Slide9.JPG
Slide9.JPG
40.41 KB
Slide10.JPG
Slide10.JPG
28.10 KB
Slide11.JPG
Slide11.JPG
60.10 KB
Slide12.JPG
Slide12.JPG
52.61 KB
Slide13.JPG
Slide13.JPG
40.03 KB
Slide14.JPG
Slide14.JPG
52.49 KB
Slide15.JPG
Slide15.JPG
48.36 KB
Slide16.JPG
Slide16.JPG
38.93 KB
Slide17.JPG
Slide17.JPG
56.30 KB
Slide18.JPG
Slide18.JPG
63.32 KB
Slide19.JPG
Slide19.JPG
44.32 KB
Slide20.JPG
Slide20.JPG
33.28 KB
Slide21.JPG
Slide21.JPG
38.13 KB
Slide22.JPG
Slide22.JPG
42.40 KB
Slide23.JPG
Slide23.JPG
80.48 KB
Slide24.JPG
Slide24.JPG
47.59 KB
Slide25.JPG
Slide25.JPG
58.57 KB
Slide26.JPG
Slide26.JPG
64.55 KB
Slide27.JPG
Slide27.JPG
45.13 KB
Slide28.JPG
Slide28.JPG
29.64 KB
Slide29.JPG
Slide29.JPG
70.90 KB
Slide30.JPG
Slide30.JPG
31.01 KB
Slide31.JPG
Slide31.JPG
77.50 KB
Slide32.JPG
Slide32.JPG
60.96 KB

Outline

Stenting in Trauma
Injury 2005
Grant Christey

Today
Vascular stenting
 Thoracic aorta
 Carotids
 Subclavian arteries
 The rest
 Non-vascular stenting
 The Future

Progress
 First proposed by Dotter in 1969
 Reported in humans in 1983
 To date..
 Most vital vessels have been stented
 Covered stents developed
 Open arteriotomy or percutaneous routes
 Technical skills, stent technology and delivery systems continue to evolve

Aims of Vascular stenting
 Occlude injury to walls of vital arteries without compromising flow
 Exclude pseudo-aneurysms or fistulas
 Prevent backflow of embolic materials into vital arteries after branch embolisation

Advantages
 Endovascular approach is from a distant non-injured site
 Avoids morbidity from surgical access and difficult surgical dissection and repair in injured tissue
 Most beneficial in the critically ill where anaesthesia or vascular reconstruction may be hazardous
 Useful for delayed diagnosis or rupture if surgical access is limited (hostile abdomen)

Advances
 Reduced patient transport, time to repair, and time to haemostasis.
 Effective and minimally invasive.
 Commercial stents replace ‘homemade” ones.
 Young trauma victims have good vessels
 We are getting better at it.

Pic of covered stent
Short term outcomes are promising
Arterial stenting - multiple series axillary/subclavian/aorta/iliac/femoral
[Rich NM et al. Vascular Trauma 2nd ed 2004]
 Technical success 94-100%
 Complication rate 0-7%
 Primary patency 85-100%
 Mean follow-up 10-18 months

But….
 Operator dependent and resource intensive
 Rare complications include rupture, dissection, immediate or late occlusion
 Lack of long term follow-up
 Still need to operate if unstable, multi-traumatised, or wounds contaminated.

Thoracic aortic rupture
 Pre-hospital death rate of 80-90%.
 Usually involves injury at the level of the isthmus causing aortic transection with pseudo-aneurysm
 Standard treatment is open repair
 But, 8-33% mortality and 2-26% paraplegia rates
(Jahromi et al. J Vasc Surg. 2001;34:1029-34)
 Stenting is emerging as the primary method to treat blunt aortic injuries

Thoracic aortic stents
 Avoid the morbidity of open repair, bypass, heparinisation and one-lung anaesthesia
 Good for pseudo-aneurysms and A-V fistulas, and useful in high-risk multi-trauma or co-morbid patients.
 Multiple small series have shown impressive results
 Commercial stents are now available

Successful stenting requires
 Adequate vascular access via iliac artery and aorta
 Minimal aortic tortuosity
 lesion >15 cm above celiac artery and >5mm from left subclavian artery
Therasse et al. Radiographics 2005;25:157-173

Complications
( 9 stent studies 1996-2003)
Dunham et al. J Trauma 2004;56(6):1173-78
Stent Open
 Technical success 98.5% 75-95%
 Overall mortality 5.9% 5-28%
 Paraplegia 0% 9-26%
 Endoleaks 7.4%
 Graft-related death rate 1.5%
But….
 Graft durability is unknown over a lifetime of dynamic motion in a thoracic aorta.
 Grafts can migrate.
 5-20% endoleak rate in proximal lesions.
 Long term effects of covering subclavian origin and vertebral are unknown.
 No large trials have been done validating the technique. (The current AAST Multicentre Trial may solve this.)

Carotid stenting is controversial
Coldwell et al. J Trauma. 2000 Mar;48(3):470-2
 27 pts with extracranial ICA injury
 0% stroke rate at 2.5 yrs

Clothren et al. Arch Surg. 2005 May;140(5):480-5
 46 pts with extracranial ICA injury
 23 pts got stents for pseudoaneurysms after 7-10 days of anticoagulation
 45% reocclusion rate
 10% stroke rate

Joo et al. J Trauma 2005 June; 58(6):1159
 6 pts stented for intra- and extra-cranial ICA injuries
 no vascular or neurologic complications at 20 months

Cohen et al. Stroke. April 2005;36(4):45-7
 10 pts stented ICA injury and high stroke risk (cerebral hypoperfusion or failed anticoagulation)
 mean dissection stenosis 69% -> 8%
 no neurologic complications at 16 months
ICA Injury
Penetrating
Operate if hard signs present, or injury is accessible

Blunt
Standard treatment is anticoagulation
Other options..
(a) Accessible to surgeon (below C2):
Operative repair or temporary balloon occlusion then repair.
(b) Inaccessible:
Embolisation, stenting or combinations.

Carotid pics
Joo et al Fig2
Carotid Stenting Summary
 Indications for carotid stenting in trauma are unclear
 Useful in inaccessible lesions, esp at the skull base
 Medium term results encouraging but no long term outcome studies to date
Subclavian artery stent

A wave of vascular stents
 Axillary artery
Papaconstantinou et al. J Trauma 2004;57:180-83
 Axillary vein
Kumar J. Vasc Surg Dec 2004;40(6):1243-4
 Subclavian artery
Xenos et al. J Vasc SurgSep 2003 38(3):451-4
 Subclavian vein
Jeroukhimov et al. J Trauma 2004;57:1329-30
 Renal artery
Inoue et al. J Urol. 2004; 171:347-8
 IVC
De Naeyer et al. J Vasc surg 2005 Mar;41(3):552-4

More vascular stents
 Cervicothoracic arteriovenous fistulas
DuTiot et al. BJS. Dec 2003 90(12):1516-21
 Brachial artery
Maynar et al. J Trauma 2004; 56:1336-41
 Iliac Arteries
Shah et al. J Trauma 2003;55:383-5
 Bilateral iliac occlusion
Sternbergh et al. J Vasc Surg. Sept 2003;38(3):589-92
 Iliac veins
Kataoka et al. J Trauma 2005 Apr; 58(4):704-8
 SMA
Appel et al. J Vasc Intervent. Radiol. 2003;14:917-22

Non-vascular stenting
 Ureters
 Commonly used. Mandatory adjunct to operative and non-operative treatment
 Pancreas
 Early open surgery is standard.
 Stents useful for fistulas. Beware late strictures.
 Emerging primary role in children
Canty et al J Trauma 2001;50:1001-7
 Biliary
 Surgery standard if extrahepatic
 Stents useful if intrahepatic
Nathan et al. Surg Laparosc Percut Tech.Oct 2003;13(5):350-2
D’amours et al. J Trauma 2001;51:159-61
 Larynx
 Soft, sutured stents for comminuted fractures and mucosal damage. Remove 2-3/52
Hwang SY et al. J Laryngol Otol. 2004 May;118(5):325-8.
 Bronchus
 Early surgery is best. Consider stents for delayed diagnoses.
Sim et al. Sing Med J 1999; 40(6)

The Future
 Exciting and expanding field
 Improvement in techniques, imaging and stent technology and delivery systems
 Success requires combined skills of surgeons and interventionists
 New systems and protocols will develop as the data matures
The Last Word
“The long-term consequences of endovascular stents in trauma are not yet defined”


Created by IrfanView